Study: Epstein Barr virus protects against autoimmune disease

April 2, 2012, National Jewish Health

To the surprise of investigating researchers, an animal model of Epstein Barr virus protected lupus-prone mice against development of the autoimmune disease. Earlier work had suggested that EBV might promote the development of autoimmunity.

"We were completely surprised. So, we redid the experiments, and the results came out the same," said Dr. Pelanda, lead author on the paper appearing online in the Proceesing of the National Academy of Sciences. "We believe these findings could lead to therapeutic targets for lupus and other autoimmune diseases."

(EBV) infects most people in the United States by the time they are adults. It causes mononucleosis in about 35 to 50 percent of those infected. Acute symptoms usually pass within weeks, after which the virus goes into a dormant state within the body. The infection persists for a person's entire life and can activate in some cases.

Although the virus infects the vast majority of adults, it is found in an even higher percentage of , leading to the hypothesis that it may predispose people to .

EBV does not infect mice, but a related virus, gammahervesvirus 68, does and has a similar pattern of infection and symptoms. So Dr. Pelanda and her colleagues infected a mouse model of lupus with the virus. One hundred percent of the lupus model mice develop lupus by about one year of age.

In those mice infected with the gammaherpesvirus 68, however, antibodies associated with lupus did not increase, and actually decreased significantly in female mice. In kidneys, a major site of tissue damage in lupus, viral infection reduced tissue damage from 80 percent to 20 percent. Other measures of lupus, including activation of lymphocytes and , were also reduced in lupus-prone mice infected with the gammaherpesvirus 68.

"The virus inhibits the development and progression of lupus on many levels, from cellular to humoral and organ," said Dr. Pelanda. "For that reason, we believe it is affecting a basic mechanisms of ."

The researchers do not know how the gammaherpesvirus inhibits lupus, but have begun a systematic series of experiments to evaluate several potential mechanisms.

Explore further: NIH scientists outline steps toward Epstein-Barr virus vaccine

More information: “Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity,” by Jennifer D. Larson et al. PNAS, 2012.

Related Stories

NIH scientists outline steps toward Epstein-Barr virus vaccine

November 2, 2011
Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood ...

First lupus breakthrough in 50 years

April 28, 2011
(Medical Xpress) -- A Monash researcher has played a crucial role in the first major lupus treatment breakthrough for over 50 years.

Recommended for you

Protein found in patients with severe asthma can help identify who would benefit from targeted drugs

October 22, 2018
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways. These patients with the type 2 (T2) endotype may benefit ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.